MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 274 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2024. The put-call ratio across all filers is 1.27 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $36,569,005 | +4.9% | 130,529 | 0.0% | 29.98% | -9.2% |
Q1 2024 | $34,856,464 | +115311.1% | 130,529 | 0.0% | 33.02% | +19.5% |
Q4 2023 | $30,202 | +166.3% | 130,529 | +68.1% | 27.63% | +214.5% |
Q3 2023 | $11,342 | -36.8% | 77,657 | 0.0% | 8.78% | -33.1% |
Q2 2023 | $17,939 | -4.7% | 77,657 | 0.0% | 13.14% | -12.2% |
Q1 2023 | $18,814 | -16.5% | 77,657 | 0.0% | 14.97% | -11.7% |
Q4 2022 | $22,540 | -99.6% | 77,657 | 0.0% | 16.95% | +412.3% |
Q3 2022 | $5,047,000 | -9.2% | 77,657 | 0.0% | 3.31% | -14.0% |
Q2 2022 | $5,559,000 | -27.0% | 77,657 | 0.0% | 3.85% | +38.5% |
Q1 2022 | $7,620,000 | +15.8% | 77,657 | 0.0% | 2.78% | +38.2% |
Q4 2021 | $6,581,000 | +60.5% | 77,657 | +51.1% | 2.01% | +84.0% |
Q3 2021 | $4,101,000 | -18.1% | 51,396 | 0.0% | 1.09% | -4.9% |
Q2 2021 | $5,007,000 | -16.7% | 51,396 | 0.0% | 1.15% | -33.8% |
Q1 2021 | $6,012,000 | +5.2% | 51,396 | 0.0% | 1.74% | +23.6% |
Q4 2020 | $5,714,000 | -6.4% | 51,396 | 0.0% | 1.40% | -28.6% |
Q3 2020 | $6,103,000 | – | 51,396 | – | 1.97% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Paulson & Co. | 1,850,000 | $518,296,000 | 38.31% |
Tao Capital Management LP | 130,529 | $36,569,005 | 29.98% |
University of Wisconsin Foundation | 45,730 | $12,811,717 | 14.42% |
AlpInvest Partners B.V. | 84,595 | $23,700,135 | 8.50% |
RTW INVESTMENTS, LP | 1,915,862 | $536,747,898 | 8.31% |
Propel Bio Management, LLC | 43,032 | $12,055,845 | 7.82% |
Avoro Capital Advisors LLC | 2,055,555 | $575,884,289 | 7.67% |
Baker Brothers Advisors | 1,974,590 | $553,201,134 | 7.07% |
Tri Locum Partners LP | 65,352 | $18,309,016 | 4.63% |
TCG Crossover Management, LLC | 149,283 | $41,823,125 | 4.36% |